Author:
Tao Li-Li,Cheng Yuan-Yuan,Ding Di,Mei Shuang,Xu Jia-Wen,Yu Juan,Ou-Yang Qi,Deng Long,Chen Qi,Li Qing-Quan,Xu Zu-De,Liu Xiu-Ping
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Biochemistry, medical,Cell Biology,Clinical Biochemistry,Pharmaceutical Science,Pharmacology
Reference34 articles.
1. Elsharkawy AM, Oakley F, Mann DA (2005) The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. Apoptosis 10:927–939
2. Reeves HL, Friedman SL (2002) Activation of hepatic stellate cells—a key issue in liver fibrosis. Front Biosci 7:D808–D826
3. Toyoki Y, Sasaki M, Narumi S, Yoshihara S, Morita T, Konn M (1998) Semiquantitative evaluation of hepatic fibrosis by measuring tissue hydroxyproline. Hepatogastroenterology 45:2261–2264
4. Maher JJ (2001) Interactions between hepatic stellate cells and the immune system. Semin Liver Dis 21:417–426
5. Iredale JP, Benyon RC, Arthur MJP et al (1996) Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis. Hepatology 24:176–184
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献